CALLISTO PHARMACEUTICALS ANNOUNCES COLLABORATION WITH INSTITUTE OF HEPATITIS VIRAL RESEARCH

Callisto Pharmaceuticals, Inc., a developer of novel drug treatments in the fight against hematological cancers and other diseases and conditions, today announced a research collaboration with the Institute of Hepatitis Viral Research (IHVR) to further develop its biodefense program. The IHVR and the Drexel Institute of Biotechnology and Viral Research (DIBVIR) are located in Doylestown, PA and are affiliated with Drexel University in Philadelphia, PA.
Business Wire